Trial intelligence / Profile preview

Autologous ADMSCs vs Hyaluronic Acid in Knee Osteoarthritis

NCT07901790Recruiting

Sponsor
Yonsei University
Start
Sep 2026
Primary completion
Feb 2028
Countries
1
01

Overview

Randomised, single-blind trial of autologous adipose-derived mesenchymal stromal cells in knee osteoarthritis (OA) (2 arms), sponsored by Yonsei University. Primary endpoint: Western Ontario and McMaster Universities Osteoarthritis Index Total Score at 6 months. Started Sep 2026; status: recruiting.

02

Drugs

autologous adipose-derived mesenchymal stromal cells
03

Conditions

knee osteoarthritis (OA)

Beyond the preview

Go deeper on NCT07901790.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07901790.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call